04863nam 2200637Ia 450 991082105310332120240410164807.01-61942-445-2(CKB)2550000001040724(EBL)3017925(SSID)ssj0000826955(PQKBManifestationID)12359643(PQKBTitleCode)TC0000826955(PQKBWorkID)10809235(PQKB)11740175(MiAaPQ)EBC3017925(Au-PeEL)EBL3017925(CaPaEBR)ebr10654896(OCoLC)923654335(EXLCZ)99255000000104072420111223d2012 uy 0engur|n|---|||||txtccrMagnetic nanoparticles[electronic resource] properties, synthesis and applications /Beate Acklin and Edon Lautens, editors1st ed.New York Nova Science Publishersc20121 online resource (336 p.)Nanotechnology science and technologyPhysics research and technologyDescription based upon print version of record.1-61942-424-X Includes bibliographical references and index.""MAGNETIC NANOPARTICLES ""; ""MAGNETIC NANOPARTICLES ""; ""CONTENTS""; ""PREFACE ""; ""FORMULATIONS FOR LOCAL, MAGNETICALLY MEDIATED HYPERTHERMIA TREATMENT OF SOLID TUMORS ""; ""ABSTRACT ""; ""1. INTRODUCTION: UNDERSTANDING THE COMPLEXITY OF HYPERTHERMIA ""; ""1.1. Biological and Clinical Rationale for Induced Hyperthermia ""; ""1.1.1. Heat Effects and Toxicity at Cellular Level""; ""Morphostructural Changes Induced by Heat ""; ""Metabolic Effects of Heat ""; ""Heat Cytotoxicity and Thermal Dosimetry ""; ""Molecular Biology of Stress Responses: Heat Shock, Hypoxia and Connections """"1.2.1. Hyperthermia in Oncology """"Hyperthermia Treatment Modalities ""; ""Hyperthermia and Solid Tumor Pathophysiology""; ""Hyperthermic Therapy Combinations, Emphasis on Embolization Procedures ""; ""Hyperthermia and Immunological Considerations ""; ""1.2. Current Technical Status of Induced Hyperthermia ""; ""1.2.1. Physical Modalities for Induced Hyperthermia ""; ""1.2.2. Inductive Modalities ""; ""1.2.3. Magnetic Losses ""; ""Hysteresis Losses ""; ""Losses by Magnetic Relaxations ""; ""2. FORMULATIONS FOR LOCAL HYPERTHERMIA TREATMENT OF HARD TISSUE TUMORS """"2.1. Magnetic Ceramic, Glass and Glass-Ceramic Materials """"2.2. Glass/Ceramic Particles and Microspheres""; ""2.3. Magnetic Materials for Cementoplasty""; ""3. FORMULATIONS AND MINIMALLY INVASIVE PROCEDURES FOR MAGNETICALLY MEDIATED LOCAL HYPERTHERMIA TREATMENT OF SOFT TISSUE TUMORS ""; ""3.1. Arterial Injections and Arterial Embolization Hyperthermia (AEH) ""; ""3.1.1. Microparticles ""; ""3.1.2. Formulation Forming-Depot ""; ""3.2. Intratumoral Direct Injection Hyperthermia (DIH)""; ""3.2.1. Formulation Forming Depot ""; ""3.2.2. Formulations Forming Implants In Situ """"4. MAGNETIC LIPOSOMES AND LOCAL HYPERTHERMIA TREATMENT OF TUMORS """"4.1. General Characteristics of Liposomes ""; ""4.2. Magnetoliposomes and Magnetically Induced Local Hyperthermia of Tumor""; ""4.3. Immunoconjugated Magnetoliposomes for the Systemic Approach of Magnetically Mediated Hyperthermia of Solid Tumors ""; ""4.3.1. Magnetoliposomes Conjugated with Anti CA9 (Human MN) Antigen Antibodies ""; ""4.3.2. Magnetoliposomes Coupled with Anti-HER2 Antibodies ""; ""Anti-HER2 Immunoconjugated Magnetoliposomes and Pharmaceutical Considerations Associated with Anti-HER2 Antibodies""""Anti-HER2 Immunoconjugated Magnetoliposomes and Micropharmacology Considerations Associated with Non Magnetic Anti-HER2 Immunoliposomes""""4.4. Cationic Magnetoliposomes in Bone Metastasis of Prostate Cancer Model ""; ""4.5. Neutral Magnetoliposomes: Targeting Draining Lymphatic Nodes for Magnetic Hyperthermia ""; ""CONCLUSION ""; ""ACKNOWLEDGMENTS ""; ""6. LIST OF ABBREVIATIONS, UNITS, NOTATIONS AND SYMBOLS""; ""REFERENCES ""; ""ORGANIC BASED MAGNETIC NANOPARTICLES-POLYMERS AND VARIOUS CALIXARENE BASED MAGNETIC NANOPARTICLES ""; ""ABSTRACT ""; ""INTRODUCTION""""1. MAGNETIC NANOPARTICLE- POLYMERS ""Nanotechnology science and technology series.NanoparticlesMagnetic propertiesNanostructuresMagnetic propertiesNanoparticlesMagnetic properties.NanostructuresMagnetic properties.620.1/15Acklin Beate1669875Lautens Edon1669876MiAaPQMiAaPQMiAaPQBOOK9910821053103321Magnetic nanoparticles4031339UNINA